Corvus Pharmaceuticals宣布将于2026年8月6日发布业务更新及第二季度财务业绩

美股速递
Jul 31

Corvus Pharmaceuticals, Inc. (CRVS) 计划在2026年8月6日这一天,向市场公布其业务进展报告以及2026年第二季度的财务表现。届时,公司将通过这一公告,向投资者及公众详细阐述其近期的运营状况与财务成果,相关内容将涵盖公司策略的调整与关键项目的推进情况。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10